Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
36.15
+0.08 (0.22%)
May 23, 2025, 3:00 PM CST
SHA:600211 Market Cap
SHA:600211 has a market cap or net worth of 11.65 billion as of May 23, 2025. Its market cap has decreased by -1.58% in one year.
Market Cap
11.65B
Enterprise Value
9.08B
Revenue
2.81B
Ranking
n/a
PE Ratio
11.55
Stock Price
36.15
Market Cap Chart
Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 11.65B, an increase of 704.66%. That is a compound annual growth rate of 8.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 366.93B |
Shenzhen Mindray Bio-Medical Electronics | 272.84B |
WuXi AppTec | 179.48B |
Zhangzhou Pientzehuang Pharmaceutical., | 124.55B |
Aier Eye Hospital Group | 117.89B |
Shanghai United Imaging Healthcare | 112.34B |
Sichuan Biokin Pharmaceutical | 111.48B |
Yunnan Baiyao Group Co.,Ltd | 101.17B |